Stock screenerAll disclosures →
EDGAR →
ROIV
Conviction 84HealthcareScan · Mon, Aug 10, 2026ROIV$35.79-1.53%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
6
7
Vol MA14 5.26M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price35.79
Change-1.53%
Gap-0.80%
Rel volume1.18×
Avg volume4.94M
Avg $ vol171.01M
SMA 2034.59
SMA 5033.11
SMA 20026.95
Price vs 50+8.06%
Price vs 200+32.76%
MA stackbullish
50/200 cross—
Supertrenddown · 36.59
RSI (14)58
MACD hist0.06
MACD crossbull · 1d
Stoch %K / %D77 / 86
ADX (14)20
+DI / −DI25 / 21
RSI divergence—
MACD divergence—
ATR %+3.55%
ADR %3.33%
52w high36.81
52w low11.17
From 52w high-2.78%
Above 52w low+220.37%
New 52w highNo
SqueezeOn · 3d
Bollinger width8.95%
%B0.88
Donchian pos77.09%
Donchian high36.77
Donchian low32.47
AVWAP (52w high)34.67
vs AVWAP high+3.21%
AVWAP (52w low)23.62
vs AVWAP low+51.49%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d1.18×
Avg vol (14d)5.26M
Avg vol (20d)4.94M
Avg $ vol (20d)171.01M
Market cap—
RS 3m (vs SPY)+22.80%
RS 6m (vs SPY)+57.79%
RS line new highNo
Trend template8/8
Technical rank83.5
1 week+7.40%
1 month-0.51%
3 months+25.30%
6 months+38.59%
1 year+209.83%
YTD+63.18%
P/E-87.54
P/B6.20
P/S—
P/FCF-34.59
EPS-0.5400
Div yield—
ROE-7.08%
ROA-5.65%
Debt/Eq0.05
Current16.72
EV/EBITDA-49.28
Gross margin—
Net margin—
Rev growth-71.57%
EPS growth-74.30%
Price target41.43
Target upside14.04%
Analyst ratingBuy
Institutional81.86%
Ent. value25.22B
Revenue1.44M
Net income-189.84M
Gross profit—
Free cash flow-758.56M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out719.27M
Employees721
ListedFri, Oct 1, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction84 / 100
Pattern quality—
Tech rank83.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance36.45
Support31.03
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ROIV · 3 recent
Insider activity
SEC Form 4 transactions in ROIV · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Gold Daniel Allen Director · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-30 | Sell | 200K | $7.1M | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
Gold Daniel Allen Director · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
Gold Daniel Allen Director · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
SEC filings
EDGAR filings in ROIV · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.